Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors Targeting the LFA-1/ICAM-1 Cell-Adhesion Interaction: Design and Mechanism of Action

By  

Current Pharmaceutical Design, Vol. 14, Iss. 22, 2008-08 ,pp. : 2128-2139

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agents

By Saragovi H.U.   Burgess K.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 737-751

Informa Healthcare

Access to resources Recommend Favorite

Novel hydantoin derivatives useful as LFA-1 antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 97-99

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 100-112

Bentham Science Publishers

Access to resources Recommend Favorite